FOMX News
Archived Headlines
- Foamix Pharmaceuticals prices IPO at $6.00, below the range 09/18/14
- Alibaba and 6 health care IPOs planned for the week of September 15 09/15/14
- Foam-focused acne fighter Foamix Pharmaceuticals sets terms for $65 million IPO 09/03/14
- Acne biotech Foamix Pharmaceuticals files for a $75 million IPO 08/13/14
Acne cream from Israel: Sol-Gel Technologies files for an $86 million US IPO
Sol-Gel Technologies, which is developing acne creams that deliver treatment via proprietary microcapsules, filed on Tuesday with the SEC to raise up to $86 million in an initial public offering. The Ness Ziona, Israel-based company was founded in 1997 and...read more
Have acne? There's a gel for that! Klox Technologies files for a $75 million IPO
Klox Technologies, which is developing a light-reactive topical gel for acne and skin care, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering. September 2014 IPO Foamix Pharmaceuticals (FOMX), which is developing...read more
US IPO Pricing Recap: Alibaba pops 38%, represents one third of 2014 IPO market proceeds
Alibaba raised $21.8 billion in its IPO on Friday, making it the world's largest IPO ever. At $94, Alibaba commands a diluted market value of $242 billion; it is now the 10th-largest US-listed company, just behind Walmart. With one deal, the total capital raised...read more
Dermira sets terms for $80 million IPO; biotech treats scaly, sweaty, acne-covered skin
Dermira, a biotech targeting skin conditions such as psoriasis, excessive sweating and acne, announced terms for its IPO on Friday. The Redwood City, CA-based company plans to raise $80 million by offering 5.4 million shares at a price range of $14 to $16. At...read more